Physician profile
Jorge E Garrett
NPI 1609898212
$2,189.00
in general payments reported to CMS, 2019-2025
15 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $11.64 · 2021: $200 · 2022: $537 · 2023: $247 · 2024: $553 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $680.20 | 2019-2025 | Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol, Rocklatan |
| Coopervision INC. | $496.37 | 2021-2023 | Myday Contact Lens |
| Abbvie INC. | $320.77 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $170.06 | 2024-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.19 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $107.94 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $81.71 | 2023-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $67.09 | 2019-2025 | |
| Dompe US, INC. | $30.54 | 2025 | Oxervate |
| Rxsight INC | $23.76 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Harrow Eye, LLC | $22.70 | 2024 | Vevye |
| Thea Pharma INC. | $20.59 | 2024 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $19.91 | 2025 | |
| Allergan, INC. | $15.80 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.